To Assess the Effectiveness of Multiple Dose, Multiple Concentrations of Qwo, for the Treatment of Mild to Moderate Cellulite.

PHASE4CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 29, 2021

Primary Completion Date

August 15, 2021

Study Completion Date

August 31, 2021

Conditions
Cellulite
Interventions
DRUG

Qwo

Collagenase clostridium histolyticum-aaes is a combination of bacterial collagenases AUX-I and AUX-II, in an approximate 1:1 mass ratio, which are isolated and purified from the fermentation of Clostridium histolyticum bacteria. Collagenase AUX-I is a single polypeptide chain consisting of approximately 1000 amino acids. Collagenase AUX-II is a single polypeptide chain consisting of approximately 1000 amino acids.

Trial Locations (1)

06880

DMR Research, PLLC, Westport

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Endo Pharmaceuticals

INDUSTRY

lead

DMR Research, PLLC

OTHER